DNDN Insider Trading Activity and SEC Form 4 Filings
DNDN insider trading summary
No open-market insider purchases or sales of Dendreon Corp (DNDN) have been reported on SEC Form 4 in the past 12 months.
Latest DNDN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 10, 2013 | Lindsay Rocco | EVP, Corporate Communications | Sell | $24K (8,207 @ $2.94) |
| Aug 1, 2012 | Gerardo Canet | Director | Buy | $44K (10,000 @ $4.38) |
| Apr 23, 2012 | Mark W Frohlich | See Remarks | Sell | $28K (2,687 @ $10.56) |
| Jan 23, 2012 | Mark W Frohlich | See General Remarks | Sell | $43K (3,230 @ $13.24) |
| Nov 14, 2011 | Mark W Frohlich | See General Remarks | Sell | $54K (7,500 @ $7.20) |
| Nov 7, 2011 | Gregory T Schiffman | CFO, SVP of Finance & Treasure | Buy | $200K (30,030 @ $6.66) |
| Nov 4, 2011 | John Johnson | Director | Buy | $17K (2,500 @ $6.68) |
| Oct 21, 2011 | Mark W Frohlich | See General Remarks | Sell | $33K (3,230 @ $10.17) |
| Oct 21, 2011 | David Urdal | SVP, Chief Scientific Officer | Sell | $10K (1,016 @ $10.10) |
| Oct 17, 2011 | David Urdal | SVP, Chief Scientific Officer | Sell | $20K (2,036 @ $9.65) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.